{"id":"https://openalex.org/W4416626679","doi":"https://doi.org/10.1158/1078-0432.30705908","title":"Table S1 from Anlotinib plus Epirubicin Followed by Anlotinib Maintenance as First-line Treatment for Advanced Soft-tissue Sarcoma: An Open-label, Single-arm, Phase II Trial","display_name":"Table S1 from Anlotinib plus Epirubicin Followed by Anlotinib Maintenance as First-line Treatment for Advanced Soft-tissue Sarcoma: An Open-label, Single-arm, Phase II Trial","alternate_titles":[],"publication_year":2025,"publication_date":"2025-11-25","ids":{"openalex":"https://openalex.org/W4416626679","doi":"https://doi.org/10.1158/1078-0432.30705908"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.30705908","doi":"https://doi.org/10.1158/1078-0432.30705908","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30705908","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"parent_works":[],"lineage":["https://openalex.org/W4416626679"],"child_works_count":0,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.30705908","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014874006","display_name":"Zhiming Wang","orcid":"https://orcid.org/0000-0002-7605-377X","observed_orcids":["https://orcid.org/0000-0002-7605-377X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhi-ming Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7605-377X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113447042","display_name":"Rongyuan Zhuang","orcid":"https://orcid.org/0000-0002-2787-6446","observed_orcids":["https://orcid.org/0000-0002-2787-6446"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rong-yuan Zhuang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2787-6446","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027049354","display_name":"Xi Guo","orcid":"https://orcid.org/0000-0002-3152-0282","observed_orcids":["https://orcid.org/0000-0002-3152-0282"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xi Guo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3152-0282","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066081640","display_name":"Chen-lu Zhang","orcid":"https://orcid.org/0000-0002-1130-8583","observed_orcids":["https://orcid.org/0000-0002-1130-8583"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chen-lu Zhang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1130-8583","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046502823","display_name":"Yang You","orcid":"https://orcid.org/0000-0002-5282-375X","observed_orcids":["https://orcid.org/0000-0002-5282-375X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yang You","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5282-375X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013571657","display_name":"Li-sha Chen","orcid":"https://orcid.org/0000-0001-8356-6795","observed_orcids":["https://orcid.org/0000-0001-8356-6795"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Li-sha Chen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8356-6795","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030491976","display_name":"W. Liu","orcid":"https://orcid.org/0000-0002-9844-4296","observed_orcids":["https://orcid.org/0000-0002-9844-4296"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wen-shuai Liu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9844-4296","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041723489","display_name":"Yong Zhang","orcid":"https://orcid.org/0000-0003-4683-752X","observed_orcids":["https://orcid.org/0000-0003-4683-752X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yong Zhang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4683-752X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041162028","display_name":"Rongkui Luo","orcid":"https://orcid.org/0000-0002-4118-7225","observed_orcids":["https://orcid.org/0000-0002-4118-7225"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rong-kui Luo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4118-7225","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018872547","display_name":"Yingyong Hou","orcid":"https://orcid.org/0000-0001-9156-2305","observed_orcids":["https://orcid.org/0000-0001-9156-2305"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ying-yong Hou","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9156-2305","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045888331","display_name":"Weiqi Lu","orcid":"https://orcid.org/0000-0002-9533-805X","observed_orcids":["https://orcid.org/0000-0002-9533-805X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei-qi Lu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9533-805X","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5064161818","display_name":"Yuhong Zhou","orcid":"https://orcid.org/0000-0001-6333-8226","observed_orcids":["https://orcid.org/0000-0001-6333-8226"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yu-hong Zhou","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6333-8226","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12278","display_name":"Vascular Tumors and Angiosarcomas","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anlotinib","display_name":"anlotinib","score":0.9950000047683716},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/advanced-soft-tissue-sarcoma","display_name":"advanced soft tissue sarcoma","score":0.9390000104904175},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.9269999861717224},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.8059999942779541},{"id":"https://openalex.org/keywords/participant-representativeness","display_name":"study participant representativeness","score":0.7429999709129333}],"concepts":[{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.5278000235557556},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.5184999704360962},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.5001000165939331},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46799999475479126},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.301800012588501},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2851000130176544},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27880001068115234},{"id":"https://openalex.org/C136229726","wikidata":"https://www.wikidata.org/wiki/Q327092","display_name":"Biomedical engineering","level":1,"score":0.2644999921321869},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.26089999079704285},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2425999939441681}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.30705908","doi":"https://doi.org/10.1158/1078-0432.30705908","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30705908","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/30705908","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Table_S1_from_Anlotinib_plus_Epirubicin_Followed_by_Anlotinib_Maintenance_as_First-line_Treatment_for_Advanced_Soft-tissue_Sarcoma_An_Open-label_Single-arm_Phase_II_Trial/30705908","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.30705908","doi":"https://doi.org/10.1158/1078-0432.30705908","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.30705908","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4306147499","https://openalex.org/W4361954642","https://openalex.org/W3167433730","https://openalex.org/W4282046192","https://openalex.org/W4285506094","https://openalex.org/W3169071014","https://openalex.org/W2965924477","https://openalex.org/W3002673813","https://openalex.org/W4410799906","https://openalex.org/W4392801670"],"abstract_inverted_index":{"Representativeness":[0],"of":[1],"Study":[2],"Participants":[3]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4416626679","counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2025-11-25T00:00:00"}
